AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 3.290
+0.110 (3.46%)
Nov 3, 2026, 2:37 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 69.63 million as of November 3, 2026. It is the 43,218th most valuable company in the world and the 639th biggest in Sweden. Its market cap has increased by 21.40% in one year.
Market Cap
69.63M
Enterprise Value
60.15M
Revenue
9.31M
Global Rank
Country Rank
#639 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since January 9, 2017, AcouSort AB's market cap has increased from 65.36M to 69.63M, an increase of 6.53%. That is a compound annual growth rate of 0.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 69.63M | 16.25% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 139.73M |
| Xintela AB | 134.36M |
| Initiator Pharma | 133.14M |
| Alzinova AB | 112.04M |
| Active Biotech AB | 105.31M |
| OncoZenge AB | 85.84M |
| Ascelia Pharma AB | 77.45M |
| Pila Pharma AB | 71.26M |